Literature DB >> 29289682

L-ascorbic acid: A true substrate for HIF prolyl hydroxylase?

Andrey I Osipyants1, Andrey A Poloznikov2, Natalya A Smirnova1, Dmitry M Hushpulian1, Anna Yu Khristichenko1, Tatiana A Chubar3, Arpenik A Zakhariants3, Manuj Ahuja4, Irina N Gaisina5, Bobby Thomas4, Abe M Brown6, Irina G Gazaryan7, Vladimir I Tishkov8.   

Abstract

L-Ascorbate (L-Asc), but not D-isoascorbate (D-Asc) and N-acetylcysteine (NAC) suppress HIF1 ODD-luc reporter activation induced by various inhibitors of HIF prolyl hydroxylase (PHD). The efficiency of suppression by L-Asc was sensitive to the nature of HIF PHD inhibitor chosen for reporter activation. In particular, the inhibitors developed to compete with alpha-ketoglutarate (αKG), were less sensitive to suppression by the physiological range of L-Asc (40-100 μM) than those having a strong iron chelation motif. Challenging those HIF activators in the reporter system with D-Asc demonstrated that the D-isomer, despite exhibiting the same reducing potency with respect to ferric iron, had almost no effect compared to L-Asc. Similarly, no effect on reporter activation was observed with cell-permeable reducing agent NAC up to 1 mM. Docking of L-Asc and D-Asc acid into the HIF PHD2 crystal structure showed interference of Tyr310 with respect to D-Asc. This suggests that L-Asc is not merely a reducing agent preventing enzyme inactivation. Rather, the overall results identify L-Asc as a co-substrate of HIF PHD that may compete for the binding site of αKG in the enzyme active center. This conclusion is in agreement with the results obtained recently in cell-based systems for TET enzymes and jumonji histone demethylases, where L-Asc has been proposed to act as a co-substrate and not as a reducing agent preventing enzyme inactivation.
Copyright © 2018 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved.

Entities:  

Keywords:  Adaptaquin; Catalytic cycle; HIF PHD inhibitor; HIF1 ODD-Luciferase reporter assay; Jumonji demethylase; TET enzyme

Mesh:

Substances:

Year:  2017        PMID: 29289682      PMCID: PMC6460286          DOI: 10.1016/j.biochi.2017.12.011

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  43 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues.

Authors:  Qi Chen; Michael Graham Espey; Murali C Krishna; James B Mitchell; Christopher P Corpe; Garry R Buettner; Emily Shacter; Mark Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-12       Impact factor: 11.205

3.  A conserved family of prolyl-4-hydroxylases that modify HIF.

Authors:  R K Bruick; S L McKnight
Journal:  Science       Date:  2001-10-11       Impact factor: 47.728

4.  Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells.

Authors:  Helen J Knowles; Raju R Raval; Adrian L Harris; Peter J Ratcliffe
Journal:  Cancer Res       Date:  2003-04-15       Impact factor: 12.701

5.  The prolyl 4-hydroxylase inhibitor ethyl-3,4-dihydroxybenzoate generates effective iron deficiency in cultured cells.

Authors:  Jian Wang; Joan L Buss; Guohua Chen; Prem Ponka; Kostas Pantopoulos
Journal:  FEBS Lett       Date:  2002-10-09       Impact factor: 4.124

6.  The effects of ascorbic acid on cartilage metabolism in guinea pig articular cartilage explants.

Authors:  Amy G Clark; Amy L Rohrbaugh; Ivan Otterness; Virginia B Kraus
Journal:  Matrix Biol       Date:  2002-03       Impact factor: 11.583

7.  Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1.

Authors:  Huasheng Lu; Clifton L Dalgard; Ahmed Mohyeldin; Thomas McFate; A Sasha Tait; Ajay Verma
Journal:  J Biol Chem       Date:  2005-10-13       Impact factor: 5.157

8.  Determination and comparison of specific activity of the HIF-prolyl hydroxylases.

Authors:  Jason R Tuckerman; Yuguang Zhao; Kirsty S Hewitson; Ya-Min Tian; Christopher W Pugh; Peter J Ratcliffe; David R Mole
Journal:  FEBS Lett       Date:  2004-10-08       Impact factor: 4.124

9.  Vitamin C pharmacokinetics: implications for oral and intravenous use.

Authors:  Sebastian J Padayatty; He Sun; Yaohui Wang; Hugh D Riordan; Stephen M Hewitt; Arie Katz; Robert A Wesley; Mark Levine
Journal:  Ann Intern Med       Date:  2004-04-06       Impact factor: 25.391

10.  The first direct characterization of a high-valent iron intermediate in the reaction of an alpha-ketoglutarate-dependent dioxygenase: a high-spin FeIV complex in taurine/alpha-ketoglutarate dioxygenase (TauD) from Escherichia coli.

Authors:  John C Price; Eric W Barr; Bhramara Tirupati; J Martin Bollinger; Carsten Krebs
Journal:  Biochemistry       Date:  2003-06-24       Impact factor: 3.162

View more
  9 in total

Review 1.  High-Dose Vitamin C for Cancer Therapy.

Authors:  Ali Mussa; Ros Akmal Mohd Idris; Naveed Ahmed; Suhana Ahmad; Ahmad Hafiz Murtadha; Tengku Ahmad Damitri Al Astani Tengku Din; Chan Yean Yean; Wan Faiziah Wan Abdul Rahman; Norhafiza Mat Lazim; Vuk Uskoković; Khalid Hajissa; Noor Fatmawati Mokhtar; Rohimah Mohamud; Rosline Hassan
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-03

2.  Vitamin C effects on 5-hydroxymethylcytosine and gene expression in osteoblasts and chondrocytes: Potential involvement of PHD2.

Authors:  Richard C Lindsey; Shaohong Cheng; Subburaman Mohan
Journal:  PLoS One       Date:  2019-08-07       Impact factor: 3.752

3.  Kinetic parameters of human aspartate/asparagine-β-hydroxylase suggest that it has a possible function in oxygen sensing.

Authors:  Lennart Brewitz; Anthony Tumber; Christopher J Schofield
Journal:  J Biol Chem       Date:  2020-02-26       Impact factor: 5.157

4.  Causes and Consequences of A Glutamine Induced Normoxic HIF1 Activity for the Tumor Metabolism.

Authors:  Matthias Kappler; Ulrike Pabst; Claus Weinholdt; Helge Taubert; Swetlana Rot; Tom Kaune; Johanna Kotrba; Martin Porsch; Antje Güttler; Matthias Bache; Knut Krohn; Fabian Bull; Anne Riemann; Claudia Wickenhauser; Barbara Seliger; Johannes Schubert; Bilal Al-Nawas; Oliver Thews; Ivo Grosse; Dirk Vordermark; Alexander W Eckert
Journal:  Int J Mol Sci       Date:  2019-09-24       Impact factor: 5.923

5.  Histone deacetylase 6 inhibition in urothelial cancer as a potential new strategy for cancer treatment.

Authors:  Hiroo Kuroki; Tsutomu Anraku; Akira Kazama; Yuko Shirono; Vladimir Bilim; Yoshihiko Tomita
Journal:  Oncol Lett       Date:  2020-11-20       Impact factor: 2.967

Review 6.  HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons.

Authors:  Andrey A Poloznikov; Stepan A Nersisyan; Dmitry M Hushpulian; Eliot H Kazakov; Alexander G Tonevitsky; Sergey V Kazakov; Valery I Vechorko; Sergey V Nikulin; Julia A Makarova; Irina G Gazaryan
Journal:  Front Pharmacol       Date:  2021-01-29       Impact factor: 5.810

7.  Probable Mechanisms of Doxorubicin Antitumor Activity Enhancement by Ginsenoside Rh2.

Authors:  Alexander Popov; Anna Klimovich; Olga Styshova; Alexander Tsybulsky; Dmitry Hushpulian; Andrey Osipyants; Anna Khristichenko; Sergey Kazakov; Manuj Ahuja; Navneet Kaidery; Bobby Thomas; Vladimir Tishkov; Abraham Brown; Irina Gazaryan; Andrey Poloznikov
Journal:  Molecules       Date:  2022-01-19       Impact factor: 4.411

8.  4-O-Methylascochlorin inhibits the prolyl hydroxylation of hypoxia-inducible factor-1α, which is attenuated by ascorbate.

Authors:  Tetsuya Kondo; Kenji Takeda; Ryo Muko; Akihiro Ito; Young-Chae Chang; Junji Magae; Takao Kataoka
Journal:  J Antibiot (Tokyo)       Date:  2019-02-22       Impact factor: 2.649

Review 9.  Vitamin C Deficiency in the Young Brain-Findings from Experimental Animal Models.

Authors:  Pernille Tveden-Nyborg
Journal:  Nutrients       Date:  2021-05-15       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.